A bill to amend the Workforce Innovation and Opportunity Act to address the economic and workforce impacts of substance use disorder.

What happened: On 2026-09-24, Sen. Edward J. Markey (D-MA) introduced S5524 in the 119th Congress. The bill was read twice and referred to the Committee on Health, Education, Labor, and Pensions (HELP). This is a procedural first step; the bill has not been marked up, amended, or voted on. The bill's stated purpose is to amend the Workforce Innovation and Opportunity Act (WIOA) to address the economic and workforce impacts of substance use disorder (SUD). No funding amount is specified in the provided text, and no appropriation is attached — this is an authorization-style bill that would direct WIOA programs to incorporate SUD-related workforce services.

Current status and path: The bill is at the earliest legislative stage. It must clear HELP Committee markup, pass the full Senate, pass the House, and be signed into law. With only two actions (introduction and referral) on the same day, legislative velocity is minimal. Sen. Markey is a senior Democrat but not the HELP Committee chair, so near-term passage odds are low. The 119th Congress is in its second session (2025–2027), leaving limited time for a standalone bill of this nature to advance absent a broader workforce or healthcare package.

Convergence: No related bills, live federal procurement, or presidential actions were provided in the enrichment data. The bill is an isolated workforce/SUD measure. The only clear convergence is with the broader federal push to address the opioid and stimulant crisis through workforce development — but no specific candidate signals were supplied to establish a direct or industry link. Therefore, the convergence array is empty.

Structural winners and losers: The bill, if enacted, would direct WIOA funding toward SUD-affected workers and employers. The primary beneficiaries would be workforce development boards, community-based SUD treatment providers, and employers in industries with high SUD prevalence (e.g., construction, hospitality, transportation). Publicly traded addiction treatment providers include Acadia Healthcare ($ACHC) — the largest pure-play behavioral health provider — and Universal Health Services ($UHS) through its behavioral health segment. However, the causal chain is indirect: the bill does not directly fund treatment capacity; it amends workforce development programs. The connection requires multiple inference steps (bill passage → WIOA formula changes → state workforce boards → SUD services → treatment provider referrals), which falls below the confidence gate for a direct ticker impact. Therefore, no tickers are included in the causal chains.

Timeline: The bill has no scheduled markup. The HELP Committee would need to act in the current session. Given the 119th Congress ends in January 2027, the realistic path is either a committee markup in late 2026 or inclusion in a year-end workforce/healthcare package. For retail investors, the market impact is negligible until the bill advances.